JP2022520653A5 - - Google Patents
Info
- Publication number
- JP2022520653A5 JP2022520653A5 JP2021547792A JP2021547792A JP2022520653A5 JP 2022520653 A5 JP2022520653 A5 JP 2022520653A5 JP 2021547792 A JP2021547792 A JP 2021547792A JP 2021547792 A JP2021547792 A JP 2021547792A JP 2022520653 A5 JP2022520653 A5 JP 2022520653A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962804410P | 2019-02-12 | 2019-02-12 | |
| US62/804,410 | 2019-02-12 | ||
| PCT/US2020/017129 WO2020167593A1 (en) | 2019-02-12 | 2020-02-07 | Methods and compositions for inhibiting expression of cyp27a1 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022520653A JP2022520653A (ja) | 2022-03-31 |
| JPWO2020167593A5 JPWO2020167593A5 (https=) | 2023-04-13 |
| JP2022520653A5 true JP2022520653A5 (https=) | 2023-04-13 |
Family
ID=69941447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547792A Withdrawn JP2022520653A (ja) | 2019-02-12 | 2020-02-07 | Ｃｙｐ２７ａ１の発現を阻害するための方法及び組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220186229A1 (https=) |
| EP (1) | EP3908661A1 (https=) |
| JP (1) | JP2022520653A (https=) |
| KR (1) | KR20210132661A (https=) |
| CN (1) | CN113692444A (https=) |
| AU (1) | AU2020221892A1 (https=) |
| BR (1) | BR112021015651A2 (https=) |
| CA (1) | CA3128059A1 (https=) |
| CL (2) | CL2021002120A1 (https=) |
| IL (1) | IL285367A (https=) |
| MX (1) | MX2021009754A (https=) |
| SG (1) | SG11202108532RA (https=) |
| WO (1) | WO2020167593A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024269205A1 (en) * | 2023-05-11 | 2025-12-11 | Keymed Biosciences (Us) Inc. | Dsrna molecules for regulating masp2 gene activity |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1309726E (pt) | 2000-03-30 | 2010-03-08 | Whitehead Biomedical Inst | Mediadores de interferência por rna específicos de sequência de rna |
| AU2002213489A1 (en) * | 2000-10-13 | 2002-04-22 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the cyp27a1 gene |
| US20040259247A1 (en) | 2000-12-01 | 2004-12-23 | Thomas Tuschl | Rna interference mediating small rna molecules |
| US20050159378A1 (en) | 2001-05-18 | 2005-07-21 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA) |
| JP2005508196A (ja) | 2001-11-07 | 2005-03-31 | アプレラ コーポレイション | 核酸分析の汎用ヌクレオチド |
| US20070265220A1 (en) | 2004-03-15 | 2007-11-15 | City Of Hope | Methods and compositions for the specific inhibition of gene expression by double-stranded RNA |
| WO2007030167A1 (en) | 2005-09-02 | 2007-03-15 | Nastech Pharmaceutical Company Inc. | Modification of double-stranded ribonucleic acid molecules |
| JP2012504389A (ja) * | 2008-09-22 | 2012-02-23 | ダイセルナ ファーマシューティカルズ， インコーポレイテッド | 修飾を有するｄｓＲＮＡによる遺伝子発現の特異的な阻害のための組成物および方法 |
| US8691971B2 (en) | 2008-09-23 | 2014-04-08 | Scott G. Petersen | Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference |
| US20100249214A1 (en) | 2009-02-11 | 2010-09-30 | Dicerna Pharmaceuticals | Multiplex dicer substrate rna interference molecules having joining sequences |
| AU2009336191B2 (en) | 2008-12-18 | 2017-08-24 | Novo Nordisk A/S | Extended dicer substrate agents and methods for the specific inhibition of gene expression |
| US8927513B2 (en) | 2009-07-07 | 2015-01-06 | Alnylam Pharmaceuticals, Inc. | 5′ phosphate mimics |
| WO2011133871A2 (en) | 2010-04-22 | 2011-10-27 | Alnylam Pharmaceuticals, Inc. | 5'-end derivatives |
| JP2015501155A (ja) | 2011-10-25 | 2015-01-15 | アイシス ファーマシューティカルズ， インコーポレーテッド | Ｇｃｃｒ発現のアンチセンス調整 |
| EP2928877B1 (en) | 2012-12-06 | 2020-01-22 | Merck Sharp & Dohme Corp. | Disulfide masked prodrug compositions and methods |
| JP2017522046A (ja) | 2014-06-06 | 2017-08-10 | ソルスティス バイオロジクス，リミティッド | 生物可逆的および生物不可逆的基を有するポリヌクレオチド構築物 |
| JP7105065B2 (ja) * | 2014-12-15 | 2022-07-22 | ダイセルナ ファーマシューティカルズ， インコーポレイテッド | リガンド修飾二本鎖核酸 |
| KR101916583B1 (ko) * | 2017-04-20 | 2018-11-07 | 가천대학교 산학협력단 | 칼피르조밉을 유효성분으로 함유하는 담석증의 예방 또는 치료용 약학적 조성물 |
-
2020
- 2020-02-07 CN CN202080028344.7A patent/CN113692444A/zh not_active Withdrawn
- 2020-02-07 MX MX2021009754A patent/MX2021009754A/es unknown
- 2020-02-07 CA CA3128059A patent/CA3128059A1/en active Pending
- 2020-02-07 WO PCT/US2020/017129 patent/WO2020167593A1/en not_active Ceased
- 2020-02-07 SG SG11202108532RA patent/SG11202108532RA/en unknown
- 2020-02-07 KR KR1020217026888A patent/KR20210132661A/ko not_active Withdrawn
- 2020-02-07 AU AU2020221892A patent/AU2020221892A1/en not_active Withdrawn
- 2020-02-07 JP JP2021547792A patent/JP2022520653A/ja not_active Withdrawn
- 2020-02-07 EP EP20713417.2A patent/EP3908661A1/en not_active Withdrawn
- 2020-02-07 BR BR112021015651-8A patent/BR112021015651A2/pt not_active Application Discontinuation
- 2020-02-07 US US17/310,579 patent/US20220186229A1/en not_active Abandoned
-
2021
- 2021-08-04 IL IL285367A patent/IL285367A/en unknown
- 2021-08-11 CL CL2021002120A patent/CL2021002120A1/es unknown
-
2023
- 2023-12-27 CL CL2023003914A patent/CL2023003914A1/es unknown